Apollo Hospitals: Additional details on Apollo Healthtech demerger scheme

Nclt Scheme FiledCore Business DivestedStrategic Transactions View source PDF Explain this filing

APOLLOHOSP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.1%Reaction day

₹8500.00

prior close

₹8475.00

announcement price

In-mkt

timing

Nifty 100market+1.2%-1.4% vs market

Hospital peers, median of 24sector+0.1%-0.2% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty 100 and 0.2 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.1

15m

-0.2

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.1+1.2-1.4+0.1-0.2

Next day

-1.2+1.7-2.9-0.4-0.8

-0.9+2.2-3.1+0.2-1.1

-1.0+2.6-3.6-0.9-0.1

-0.2+2.0-2.1-0.3+0.1

-0.4+2.5-2.8+1.3-1.6

+0.9+1.9-1.0+1.7-0.8

15d

+3.9+3.3+0.6+2.2+1.7

+5.0+2.1+2.9+2.6+2.5

+3.8+3.5+0.4+2.6+1.2

+2.5-1.7+4.2+2.6-0.1

UpDownMarket · Nifty 100Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Apollo Hospitals provided additional info on its composite scheme to transfer Apollo Healthco and Keimed into a new entity, Apollo Healthtech, which will be independently listed. Key points: 6 independent directors on the new board; Ms. Shobana Kamineni proposed as Executive Chairperson; Upside Agreement with Rasmeli is investor-funded with no cash outflow (max 9% for achieving 4x MOIC); board nomination rights waive if shareholding falls below 10%. NCLT-convened meeting to approve.

Likely market impact

Seen as a value-unlocking move for independent listing of Apollo Healthtech. Upside Agreement imposes no financial burden on existing shareholders.